Picture of Sds Optic SA logo

SDS Sds Optic SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+2.52%
3m-21.47%
6m-23.16%
1yr+11.57%
Volume Change (%)
10d/3m-20.22%
Price vs... (%)
52w High-32.44%
50d MA-5.88%
200d MA-12.74%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value32.56
Price to Tang. Book32.59
Price to Free Cashflown/a
Price to Sales306.95
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-152.43%
Return on Equity-108.09%
Operating Margin-1396.45%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Sds Optic SA EPS forecast chart

Profile Summary

SDS Optic SA is a Poland-based company engaged primarily in medical research. The Company’s primary research activity relates to the oncology sector. The Firm wishes to develop a method for early breast cancer diagnosis. The current method of diagnosis relies on biopsy and histopathology. The purpose of the tests is to identify cancer markers. The Company tries to implement InProbe method, which is faster and more accurate- the method should be able to provide results within 20 minutes. The Company is also engaged in research regarding different kinds of diseases such as fungal diseases. The Company cooperates with specialists from different fields such as biology, medicine, technology, and sciences related to medicine.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    September 30th, 2023
    Incorporated
    May 17th, 2019
    Public Since
    March 15th, 2022
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    pl flag iconWarsaw Stock Exchange
    Shares in Issue
    5,877,550
    Blurred out image of a map
    Address
    Centrum ECOTECH-COMPLEX, LUBLIN, 20-612
    Web
    https://sdsoptic.pl/
    Phone
    +48 815019463
    Auditors
    Grant Thornton Polska Sp. Z o.o. sp. k.

    SDS Share Price Performance

    Upcoming Events for SDS

    Similar to SDS

    Picture of Airway Medix SA logo

    Airway Medix SA

    pl flag iconWarsaw Stock Exchange

    Picture of Bioton SA logo

    Bioton SA

    pl flag iconWarsaw Stock Exchange

    Picture of Braster SA logo

    Braster SA

    pl flag iconWarsaw Stock Exchange

    Picture of Captor Therapeutics SA logo

    Captor Therapeutics SA

    pl flag iconWarsaw Stock Exchange

    Picture of E-Shopping SA logo

    E-Shopping SA

    pl flag iconWarsaw Stock Exchange

    FAQ